NR3C2 and chronic kidney disease: Indeed, treatment with MR antagonists, especially spironolactone, has been shown to have favorable effects in patients with CKD of various etiologies by reducing albuminuria and the degree of estimated glomerular filtration rate (eGFR) decrease [14].